BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 23637601)

  • 1. Accelerated in vivo proliferation of memory phenotype CD4+ T-cells in human HIV-1 infection irrespective of viral chemokine co-receptor tropism.
    Zhang Y; de Lara C; Worth A; Hegedus A; Laamanen K; Beverley P; Macallan D
    PLoS Pathog; 2013; 9(4):e1003310. PubMed ID: 23637601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Naïve and memory cell turnover as drivers of CCR5-to-CXCR4 tropism switch in human immunodeficiency virus type 1: implications for therapy.
    Ribeiro RM; Hazenberg MD; Perelson AS; Davenport MP
    J Virol; 2006 Jan; 80(2):802-9. PubMed ID: 16378982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of HIV tropism on decreases in CD4 cell count, clinical progression, and subsequent response to a first antiretroviral therapy regimen.
    Waters L; Mandalia S; Randell P; Wildfire A; Gazzard B; Moyle G
    Clin Infect Dis; 2008 May; 46(10):1617-23. PubMed ID: 18419499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a CCR5-expressing T cell subset that is resistant to R5-tropic HIV infection.
    Oswald-Richter K; Grill SM; Leelawong M; Tseng M; Kalams SA; Hulgan T; Haas DW; Unutmaz D
    PLoS Pathog; 2007 Apr; 3(4):e58. PubMed ID: 17465678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell turnover and cell tropism in HIV-1 infection.
    Davenport MP; Zaunders JJ; Hazenberg MD; Schuitemaker H; van Rij RP
    Trends Microbiol; 2002 Jun; 10(6):275-8. PubMed ID: 12088663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune activation correlates with and predicts CXCR4 co-receptor tropism switch in HIV-1 infection.
    Connell BJ; Hermans LE; Wensing AMJ; Schellens I; Schipper PJ; van Ham PM; de Jong DTCM; Otto S; Mathe T; Moraba R; Borghans JAM; Papathanasopoulos MA; Kruize Z; Venter FWD; Kootstra NA; Tempelman H; Tesselaar K; Nijhuis M
    Sci Rep; 2020 Sep; 10(1):15866. PubMed ID: 32985522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Female genital tract shedding of CXCR4-tropic HIV Type 1 is associated with a majority population of CXCR4-tropic HIV Type 1 in blood and declining CD4(+) cell counts.
    Haaland RE; Sullivan ST; Evans-Strickfaden T; Lennox JL; Hart CE
    AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1524-32. PubMed ID: 22369497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A CCR5
    Terahara K; Iwabuchi R; Hosokawa M; Nishikawa Y; Takeyama H; Takahashi Y; Tsunetsugu-Yokota Y
    BMC Res Notes; 2019 Apr; 12(1):242. PubMed ID: 31036079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High CD4(+) T-cell surface CXCR4 density as a risk factor for R5 to X4 switch in the course of HIV-1 infection.
    Fiser AL; Vincent T; Brieu N; Lin YL; Portalès P; Mettling C; Reynes J; Corbeau P
    J Acquir Immune Defic Syndr; 2010 Dec; 55(5):529-35. PubMed ID: 20861743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCR5 and CXCR4 expression on memory and naive T cells in HIV-1 infection and response to highly active antiretroviral therapy.
    Nicholson JK; Browning SW; Hengel RL; Lew E; Gallagher LE; Rimland D; McDougal JS
    J Acquir Immune Defic Syndr; 2001 Jun; 27(2):105-15. PubMed ID: 11404531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
    Mild M; Kvist A; Esbjörnsson J; Karlsson I; Fenyö EM; Medstrand P
    Infect Genet Evol; 2010 Apr; 10(3):356-64. PubMed ID: 19446658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of R5 and X4 human immunodeficiency virus type 1 infection on CD4+ cell proliferation and activation.
    Locher CP; Witt SA; Kassel R; Dowell NL; Fujimura S; Levy JA
    J Gen Virol; 2005 Apr; 86(Pt 4):1171-1179. PubMed ID: 15784911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
    Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
    AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering HIV-resistant human CD4+ T cells with CXCR4-specific zinc-finger nucleases.
    Wilen CB; Wang J; Tilton JC; Miller JC; Kim KA; Rebar EJ; Sherrill-Mix SA; Patro SC; Secreto AJ; Jordan AP; Lee G; Kahn J; Aye PP; Bunnell BA; Lackner AA; Hoxie JA; Danet-Desnoyers GA; Bushman FD; Riley JL; Gregory PD; June CH; Holmes MC; Doms RW
    PLoS Pathog; 2011 Apr; 7(4):e1002020. PubMed ID: 21533216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4 T cell decline following HIV seroconversion in individuals with and without CXCR4-tropic virus.
    Ghosn J; Bayan T; Meixenberger K; Tran L; Frange P; d'Arminio Monforte A; Zangerle R; de Mendoza C; Krastinova E; Porter K; Meyer L; Chaix ML;
    J Antimicrob Chemother; 2017 Oct; 72(10):2862-2868. PubMed ID: 29091208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages.
    Surdo M; Balestra E; Saccomandi P; Di Santo F; Montano M; Di Carlo D; Sarmati L; Aquaro S; Andreoni M; Svicher V; Perno CF; Ceccherini-Silberstein F
    PLoS One; 2013; 8(7):e68076. PubMed ID: 23874501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycosylphosphatidylinositol-Anchored Anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice.
    Ye C; Wang W; Cheng L; Li G; Wen M; Wang Q; Zhang Q; Li D; Zhou P; Su L
    J Virol; 2017 Feb; 91(3):. PubMed ID: 27881659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Immune Recovery and Reduction of CXCR4-Tropic HIV-1.
    Bader J; Däumer M; Schöni-Affolter F; Böni J; Gorgievski-Hrisoho M; Martinetti G; Thielen A; Klimkait T;
    Clin Infect Dis; 2017 Feb; 64(3):295-300. PubMed ID: 27838645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depletion of naive CD4 T cells by CXCR4-using HIV-1 variants occurs mainly through increased T-cell death and activation.
    Hazenberg MD; Otto SA; Hamann D; Roos MT; Schuitemaker H; de Boer RJ; Miedema F
    AIDS; 2003 Jul; 17(10):1419-24. PubMed ID: 12824778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue.
    Grivel JC; Margolis LB
    Nat Med; 1999 Mar; 5(3):344-6. PubMed ID: 10086394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.